MODE OF DEATH IN PATIENTS WITH HEART FAILURE AND LEFT VENTRICULAR EJECTION FRACTION >= 45%: INSIGHTS FROM PARAGON-HF

Patients with heart failure and preserved left ventricular ejection fraction (HFpEF) comprise a heterogeneous group including some with mildly reduced EF. We hypothesized that mode of death differs by EF in HFpEF. PARAGON-HF compared clinical outcomes with sacubitril/valsartan and valsartan in 4